Thorough evaluation of OECD principles in modelling of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives using QSARINS

References

• H. Tanaka, M. Baba, H. Hayakawa, T. Sakamaki, T. Miyasaka, M. Ubasawa, H. Takashima, K. Sekiya, I. Nitta, S. Shigeta, R.T. Walker, J. Balzarini, and E. De Clercq, A new class of HIV-1 specific 6-substituted acyclouridine derivatives: Synthesis and anti-HIV activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio)thymine (HEPT), J. Med. Chem. 34 (1991), pp. 349–357. doi:10.1021/jm00105a055
   PubMed Web of Science ®Google Scholar
• A.P. Toropova, A.A. Toropov, J.B. Veselinovi, F.N. Miljkovi, and A.M. Veselinovi, QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method, Eur. J. Med. Chem. 77 (2014), pp. 298–305. doi:10.1016/j.ejmech.2014.03.013
   PubMed Web of Science ®Google Scholar
• C. Duda-Seiman, D. Duda-Seiman, M.V. Putz, and D. Ciubotariu, QSAR modelling of anti-HIV activity with HEPT derivatives, Dig, J. Nanomater. Bios. 2 (2007), pp. 207–219.
   Web of Science ®Google Scholar
• H. Tanaka, M. Baba, M. Ubasawa, H. Takashima, K. Sekiya, I. Nitta, S. Shigeta, R.T. Walker, and T. Miyasaka, Synthesis and anti-HIV activity of 2-, 3-, and 4- substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT), J. Med. Chem. 34 (1991), pp. 1394–1399. doi:10.1021/jm00108a023
   PubMed Web of Science ®Google Scholar
• H. Tanaka, H. Takashima, M. Ubasawa, K. Sekiya, I. Nitta, M. Baba, S. Shigeta, T.R. Walker, E. De Clercq, and T. Miyasaka, Structure-activity relationships of 1-[(2-hydroxyethoxy)methyl]- 6-(phenylthio)-thymine analogues: Effect of substitutions at the C-6 phenyl ring and the C-5 position on anti-HIV-1 activity, J. Med. Chem. 35 (1992), pp. 337–345. doi:10.1021/jm00080a020
   PubMed Web of Science ®Google Scholar
• H. Tanaka, H. Takashima, M. Ubasawa, K. Sekiya, I. Nitta, M. Baba, S. Shigeta, T.R. Walker, E. De Clercq, and T. Miyasaka, Synthesis and antiviral activity of deoxy analogues of 1-[(2-hydroxyethoxy)-methyl]-6-(phenylthio) thymine (HEPT) as potent and selective anti-HIV agents, J. Med. Chem. 35 (1992), pp. 4713–4719. doi:10.1021/jm00103a009
   PubMed Web of Science ®Google Scholar
• G. Campiani, A. Ramunno, G. Maga, V. Nacci, C. Fattorusso, B. Catalanotti, E. Morelli, and E. Novellino, Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: Past, present, and future perspectives, Cur. Pharm. Des. 8 (2002), pp. 615–657. doi:10.2174/1381612024607207
   PubMed Web of Science ®Google Scholar
• D. Kireev, J. Chrétien, D. Grierson, and C. Monneret, A 3D QSAR study of a series of HEPT analogues: The influence of conformational mobility on HIV-1 reverse transcriptase inhibition, J. Med. Chem. 40 (1997), pp. 4257–4264. doi:10.1021/jm970110p
   PubMed Web of Science ®Google Scholar
• V. Montessori, N. Press, M. Harris, L. Akagi, and J.S.G. Montaner, Adverse effects of antiretroviral therapy for HIV infection, CMAJ 170 (2004), pp. 229–238.
   PubMed Web of Science ®Google Scholar
• U. Muhammad, A. Uzairu, and D. Ebuka Arthur, Review on quantitative structure activity relationship (QSAR) modeling, J. Anal. Pharm. Res. 7 (2018), pp. 240–242. doi:10.15406/japlr.2018.07.00232
   Google Scholar
• E. Estrada and A. Peña, In silico studies for the rational discovery of anticonvulsant compounds, Bioorg. Med. Chem. 8 (2000), pp. 2755–2770. doi:10.1016/S0968-0896(00)00204-2
   PubMed Web of Science ®Google Scholar
• J.A. Castillo-Garit, O. Del Toro-Cortés, M.C. Vega, M. Rolón, A. Rojas de Arias, G.M. Casañola-Martin, J.A. Escario, A. Gómez-Barrio, Y. Marrero-Ponce, F. Torrens, and C. Abad, Bond-based bilinear indices for computational discovery of novel trypanosomicidal drug-like compounds through virtual screening, Eur. J. Med. Chem. 96 (2015), pp. 238–244. doi:10.1016/j.ejmech.2015.03.063
   PubMed Web of Science ®Google Scholar
• Y. Cañizares-Carmenate, K. Mena-Ulecia, Y. Perera-Sardiña, F. Torrens, and J.A. Castillo-Garit, An approach to identify new antihypertensive agents using thermolysin as model: In silico study based on QSARINS and docking, Arab. J. Chem. 12 (2019), pp. 4861–4877. doi:10.1016/j.arabjc.2016.1010.1003
   Web of Science ®Google Scholar
• H. Le-Thi-Thu, Y. Canizares-Carmenate, Y. Marrero-Ponce, F. Torrens, and J.A. Castillo-Garit, Prediction of Caco-2 cell permeability using bilinear indices and multiple linear regression, Lett. Drug Des. Discov. 13 (2016), pp. 161–169. doi:10.2174/1570180812666150630183511
   Web of Science ®Google Scholar
• T. Miyasaka, H. Tanaka, M. Baba, H. Hayakawa, R.T. Walker, J. Balzarini, and E. De Clercq, A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine, J. Med. Chem. 32 (1989), pp. 2507–2509. doi:10.1021/jm00132a002
   PubMed Web of Science ®Google Scholar
• M. Baba, H. Tanaka, E. De Clercq, R. Pauwels, J. Balzarini, D. Schols, H. Nakashima, C.F. Perno, R.T. Walker, and T. Miyasaka, Highly specific inhibition of human immunodeficiency virus type 1 by a novel 6-substituted acyclouridine derivative, Biochem. Biophys. Res. Commun. 165 (1989), pp. 1375–1381. doi:10.1016/0006-291x(89)92756-3
   PubMed Web of Science ®Google Scholar
• Y.M. Ponce, J.A.C. Garit, F. Torrens, V.R. Zaldivar, and E.A. Castro, Atom, Atom-type, and total linear indices of the “molecular pseudograph’s atom adjacency matrix”: Application to QSPR/QSAR studies of organic compounds, Molecules 9 (2004), pp. 1100–1123. doi:10.3390/91201100
   PubMed Web of Science ®Google Scholar
• E. Hulzebos, D. Sijm, T. Traas, R. Posthumus, and L. Maslankiewicz, Validity and validation of expert (Q)SAR systems, SAR QSAR Environ. Res. 16 (2005), pp. 385–401. doi:10.1080/10659360500204426
   PubMed Web of Science ®Google Scholar
• P. Gramatica, Principles of QSAR models validation: Internal and external, QSAR Comb. Sci. 26 (2007), pp. 694–701. doi:10.1002/qsar.200610151
   Google Scholar
• P. Gramatica, N. Chirico, E. Papa, S. Cassani, and S. Kovarich, QSARINS: A new software for the development, Analysis, and validation of QSAR MLR models, J. Comput. Chem. 34 (2013), pp. 2121–2132. doi:10.1002/jcc.23361
   Web of Science ®Google Scholar
• J.M. Luco and F.H. Ferretti, QSAR based on multiple linear regression and PLS methods for the anti-HIV activity of a large group of HEPT derivatives, J. Chem. Inf. Comput. Sci. 37 (1997), pp. 392–401. doi:10.1021/ci960487o
   PubMedGoogle Scholar
• Kode srl, Dragon (software for molecular descriptor calculation) version 7.0.10. Available at https://chm.kode-solutions.net.
   Google Scholar
• P. Gramatica, N. Chirico, E. Papa, S. Cassani, S. Kovarich, and A. Sangion, QSAR research unit in environmental chemistry and ecotoxicology; software available at www.qsar.it.
   Google Scholar
• R. Todeschini and V. Consonni, Molecular Descriptors for Chemoinformatics, Vol. I & II, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, 2009.
   Google Scholar
• E. De Clercq, Non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of human immunodeficiency virus type 1 (HIV-1) infections: Strategies to overcome drug resistance development, Med. Res. Rev. 16 (1996), pp. 125–157. doi:10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO;2-2
   PubMed Web of Science ®Google Scholar